We are live on ! Find out more
APYX icon

Apyx Medical

47 hedge funds and large institutions have $49M invested in Apyx Medical in 2018 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 14 increasing their positions, 10 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

67% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 6

62% more capital invested

Capital invested by funds: $30.2M → $49M (+$18.8M)

40% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 10

9% more funds holding

Funds holding: 4347 (+4)

Holders
47
Holders Change
+4
Holders Change %
+9.3%
% of All Funds
1.08%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
10
Increased
14
Reduced
10
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of Montreal
51
Bank of Montreal
Ontario, Canada
-$4K -1,500 Closed
Barclays
52
Barclays
United Kingdom
-$1.92K -520 -92%
Bank of America
53
Bank of America
North Carolina
+$22 +6 New

APYX Hedge Fund Activity: Q2 2018 in Review

47 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q2 2018, worth a combined $49M — up 62% from $30.2M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new APYX positions and 6 closed out — a net gain of 4 holders — while 14 added to existing stakes and 10 trimmed.

The largest buyer was ProVise Management Group, opening a new position worth an estimated $1.22M. The largest seller was Dimensional Fund Advisors, cutting an estimated $326K.

  • 47 institutional investors held Apyx Medical (APYX) as of Q2 2018, up from 43 in Q1 2018.
  • Funds reported $49M of Apyx Medical stock for Q2 2018, up 62% quarter-over-quarter.
  • 10 funds opened new Apyx Medical positions in Q2 2018 and 6 closed out, a net change of +4 holders.
  • The largest Apyx Medical buyer in Q2 2018 was ProVise Management Group, an estimated $1.22M added.
  • The largest Apyx Medical seller in Q2 2018 was Dimensional Fund Advisors, an estimated $326K sold.

Based on aggregated 13F filings for Q2 2018.